Louisiana lawmakers tried a novel strategy for raising revenue, a model that proponents say might work more broadly.
Donald Trump faces the prospect of a Republican rebellion when the U.S. House votes on releasing the Epstein files next week ...
Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...
Rising passenger numbers are boosting commercial aviation; geopolitical volatility is bolstering defense investment; and tech ...
Q3 2025 Earnings Call Transcript November 14, 2025Dragonfly Energy Holdings Corp. beats earnings expectations.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ...
Ond reveals additional $100Mfunding round, partnership with New Pacific Airlines in the US, and a new route between Milan and ...
Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...
Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing ...
Looking back on at a record-breaking year for private equity deals in the aerospace and defense sector; a feature on One ...
As Chapel Hill-Carrboro City Schools enter the second quarter, the district recently gave an update on its new high school ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results